DICE Therapeutics Inc.

NASDAQ: DICE · Real-Time Price · USD
47.55
0.03 (0.06%)
At close: Aug 08, 2023, 10:00 PM

DICE Therapeutics Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2022 FY 2021
Period Ending Dec 31, 2022 Dec 31, 2021
PE Ratio
-15.05 -6.47
PEG Ratio
0.32 -0.02
PS Ratio
n/a 278.61
PB Ratio
-6.55 -3.02
P/FCF Ratio
-18.47 -7.83
P/OCF Ratio
-19.11 -7.98
OCF/S Ratio
n/a -34.93
Debt / Equity Ratio
-0.07 -0.02
Quick Ratio
38.14 29.77
Current Ratio
38.14 29.77
Asset Turnover
n/a 0.00
Interest Coverage
-129.93 -273.58
Return on Equity
0.44 0.47
Return on Assets
-0.14 -0.15
Return on Invested Capital
-0.15 -0.15
Dividend Yield
n/a n/a
Payout Ratio
n/a n/a
Gross Profit Margin
n/a 1.00
Net Profit Margin
n/a -43.09
Pretax Profit Margin
n/a -43.52
Operating Profit Margin
n/a -42.31
FCF Margin
n/a n/a
EBITDA Margin
n/a -42.19